ApprovalTrail

Ingredient

Almotriptan (Almotriptan Malate)

Products in Health Canada’s databases that list Almotriptan (Almotriptan Malate) as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Drug products
15
12 authorized now
Natural health products
0
0 active licences
Notices of Compliance
0
Products in all
15

Drug products

Authorized products first.

NameDINStatus
ALMOTRIPTAN (12.5 MG)Pro Doc Limitee · Status since Jun 201402424029Marketed
ALMOTRIPTAN (12.5 MG)Sanis Health Inc. · Status since Mar 201802466821Marketed
MYLAN-ALMOTRIPTAN (6.25 MG)Mylan Pharmaceuticals Ulc · Status since Jul 201302398435Marketed
MYLAN-ALMOTRIPTAN (12.5 MG)Mylan Pharmaceuticals Ulc · Status since Jul 201302398443Marketed
SANDOZ ALMOTRIPTAN (12.5 MG)Sandoz Canada Inc. · Status since Jul 201302405334Marketed
TEVA-ALMOTRIPTAN (12.5 MG)Teva Canada Limited · Status since Dec 201402434849Marketed
AG-ALMOTRIPTAN (6.25 MG)Angita Pharma Inc. · Status since Jul 202602570289Approved
AG-ALMOTRIPTAN (12.5 MG)Angita Pharma Inc. · Status since Jul 202602570297Approved
APO-ALMOTRIPTAN (6.25 MG)Apotex Inc. · Status since Aug 201702405792Dormant
APO-ALMOTRIPTAN (12.5 MG)Apotex Inc. · Status since Aug 201702405806Dormant
JAMP ALMOTRIPTAN (6.25 MG)JAMP Pharma Corporation · Status since Mar 202502556022Approved
JAMP ALMOTRIPTAN (12.5 MG)JAMP Pharma Corporation · Status since Mar 202502556030Approved
AXERT 12.5MG (12.5 MG)McNeil Consumer Healthcare, division of Johnson & Johnson Inc. · Status since Oct 201702248129Cancelled Post Market
AXERT 6.25MG (6.25 MG)McNeil Consumer Healthcare, division of Johnson & Johnson Inc. · Status since Oct 201702248128Cancelled Post Market
PMS-ALMOTRIPTAN (12.5 MG)Pharmascience Inc. · Status since Aug 202602441411Cancelled Pre Market